MedTrace Logo

A Clinical Study of Tobradex AF

NCT00473070 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2008-07-29

No results posted yet for this study

Summary

The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Conditions

  • Cataract

Interventions

DRUG

Tobradex AF

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Robert Faulkner · Alcon Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00473070 on ClinicalTrials.gov